Previous close | 37.70 |
Open | 37.64 |
Bid | 38.27 x 200 |
Ask | 38.33 x 100 |
Day's range | 37.35 - 38.59 |
52-week range | 26.66 - 73.13 |
Volume | |
Avg. volume | 731,740 |
Market cap | 1.871B |
Beta (5Y monthly) | 0.83 |
PE ratio (TTM) | 89.02 |
EPS (TTM) | 0.43 |
Earnings date | 01 May 2024 - 06 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 43.72 |
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that more than three million ICLs have been sold globally.1
STAAR Surgical Company ( NASDAQ:STAA ) shareholders should be happy to see the share price up 25% in the last month...
West Pharmaceutical (WST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.